Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008 Aug 6;14(2):147–150. doi: 10.1007/s11655-007-9009-z

RT-ABCDE Strategy for management and prevention of human diseases

Chun-song Hu 1
PMCID: PMC7089077  PMID: 18219448

Abstract

In this article, the authors summarized the RT-ABCDE strategy for the management and prevention of human diseases, which includes ReTro—ABCDE (Examination regularity, Disease and risk factor control, Changing lifestyle and reducing pathways of infection and spread, Biochemical and Antagonistic index control and therapeutic treatment as well as RT—Routine and Right Treatment). The RT-ABCDE strategy, a novel concept and an essential method, should be a routine strategy for disease control and prevention. It should be proposed and applied in both clinical and preventive medicine.

Key words: human disease, management, prevention, RT-ABCDE strategy

References

  • 1.Yach D., Hawkes C., Gould C.L. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291:2616–2622. doi: 10.1001/jama.291.21.2616. [DOI] [PubMed] [Google Scholar]
  • 2.He J., Gu D., Wu X. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124–1134. doi: 10.1056/NEJMsa050467. [DOI] [PubMed] [Google Scholar]
  • 3.Thomas A.J., Eberly L.E., Neaton J.D. Latino riskadjusted mortality in the men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 2005;162(6):569–758. doi: 10.1093/aje/kwi220. [DOI] [PubMed] [Google Scholar]
  • 4.Holman H. Chronic disease-the need for a new clinical education. JAMA. 2004;292(9):1057–1059. doi: 10.1001/jama.292.9.1057. [DOI] [PubMed] [Google Scholar]
  • 5.Kleinert S. Routine prenatal screening for congenital heart disease. Lancet. 1996;48(9031):836. doi: 10.1016/S0140-6736(05)64727-7. [DOI] [PubMed] [Google Scholar]
  • 6.Cho I., Blaser M.J., Francois F. Helicobacter pylori and overweight status in the United States: Data from the third national health and nutrition examination survey. Am J Epidemiol. 2005;162(6):579–584. doi: 10.1093/aje/kwi237. [DOI] [PubMed] [Google Scholar]
  • 7.Bakr A.F., Habib H.S. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;6(6):832–835. doi: 10.1007/s00246-005-0981-9. [DOI] [PubMed] [Google Scholar]
  • 8.Pfeiffer C.M., Caudill S.P., Gunter E.W. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82(2):442–450. doi: 10.1093/ajcn.82.2.442. [DOI] [PubMed] [Google Scholar]
  • 9.Aounallah Skhiri H., Ben Romdhane H., Haoula H. Secondary prevention of cardiovascular diseases: knowledge and practices of patients. Tunis Med. 2005;83(Suppl5):30–35. [PubMed] [Google Scholar]
  • 10.Karmisholt K., Gotzsche P.C. Physical activity for secondary prevention of disease. Systematic reviews of randomised clinical trials. Dan Med Bull. 2005;52(2):90–94. [PubMed] [Google Scholar]
  • 11.Shiutt A., Bolotova E.V., Khalle M. Physical exercise in secondary prevention of coronary heart disease. Kardiologiia. 2005;45(7):83–86. [PubMed] [Google Scholar]
  • 12.Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. 2005;44(3):277–281. doi: 10.1080/02841860510029572. [DOI] [PubMed] [Google Scholar]
  • 13.Condon C., McCarthy G. Lifestyle changes following acute myocardial infarction: Patients perspectives. Eur J Cardiovasc Nurs. 2006;5(1):37–44. doi: 10.1016/j.ejcnurse.2005.06.005. [DOI] [PubMed] [Google Scholar]
  • 14.Verheijden M.W., Kok F.J. Public health impact of community-based nutrition and lifestyle interventions. Eur J Clin Nutr. 2005;59(Suppl1):S66–75. doi: 10.1038/sj.ejcn.1602176. [DOI] [PubMed] [Google Scholar]
  • 15.Varady K.A., Jones P.J. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J Nutr. 2005;135(8):1829–1835. doi: 10.1093/jn/135.8.1829. [DOI] [PubMed] [Google Scholar]
  • 16.Iestra J.A., Kromhout D., van der Schouw Y.T. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112(6):924–934. doi: 10.1161/CIRCULATIONAHA.104.503995. [DOI] [PubMed] [Google Scholar]
  • 17.Maymon R., Tovbin Y., Dreazen E. All five digits of the hands of fetuses with Down syndrome are short. Ultrasound Obstet Gynecol. 2004;23(6):557–560. doi: 10.1002/uog.1074. [DOI] [PubMed] [Google Scholar]
  • 18.Brown W.M., Hines M., Fane B.A. Masculinized finger length patterns in human males and females with congenital adrenal hyperplasia. Horm Behav. 2002;42(4):380–386. doi: 10.1006/hbeh.2002.1830. [DOI] [PubMed] [Google Scholar]
  • 19.Luyckx V.A., Brenner B.M. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl. 2005;97:S68–77. doi: 10.1111/j.1523-1755.2005.09712.x. [DOI] [PubMed] [Google Scholar]
  • 20.Salle B., Picaud J.C., Lopilloune A. Mortality and morbidity of low-birth-weight infants. Current prognosis and future perspectives. Bull Acad Natl Med. 2004;188(7):1127–1139. [PubMed] [Google Scholar]
  • 21.McKie P.M., Burnett J.C., Jr. B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc. 2005;80(8):1029–1036. doi: 10.4065/80.8.1029. [DOI] [PubMed] [Google Scholar]
  • 22.Ollivier J.P., Revel F. Brain natriuretic peptide in acute coronary syndromes: utility of NT-pro BNP assay. Bull Acad Natl Med. 2004;188(9):1529–1538. [PubMed] [Google Scholar]
  • 23.Hu C.S., Gao R.L., Liu L.S. Seven core principles for the treatment of hypertension. Chin J Integr Tradit West Med (Chin) 2006;26(4):363–365. [PubMed] [Google Scholar]
  • 24.Mazer S.P., Weisfeldt M., Bai D. Reverse CPR: a pilot study of CPR in the prone position. Resuscitation. 2003;57(3):279–285. doi: 10.1016/S0300-9572(03)00037-6. [DOI] [PubMed] [Google Scholar]
  • 25.Orth-Gomer K., Albus C., Bages N. Psychosocial considerations in the European guidelines for prevention of cardiovascular diseases in clinical practice: third joint task force. Int J Behav Med. 2005;12(3):132–141. doi: 10.1207/s15327558ijbm1203_2. [DOI] [PubMed] [Google Scholar]
  • 26.Hu S.S., Wang X.Q., Xu J.P. Experiences in surgical treatment of cardiac tumors. Natl Med J China (Chin) 2006;86(11):766–770. [PubMed] [Google Scholar]
  • 27.Liu Y.L., Hu S.S., Shen X.D. Indications of arterial switch operation for complex congenital heart defect with severe pulmonary hypertension and ventriculoarterial discordant connection. Natl Med J China (Chin) 2006;86(1):23–25. [PubMed] [Google Scholar]
  • 28.Zhang S.J., Zhang H., Wei Y.J. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res. 2006;16(6):577–584. doi: 10.1038/sj.cr.7310075. [DOI] [PubMed] [Google Scholar]
  • 29.Hu C.S. “3Y” problem and principle in gene therapy. Hereditas (Chin) 2003;25(5):577–580. [PubMed] [Google Scholar]
  • 30.Graham D.J., Campen D., Hui R. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365(9458):475–481. doi: 10.1016/S0140-6736(05)17864-7. [DOI] [PubMed] [Google Scholar]
  • 31.Wei Y.D., Hu D.Y., Zhang R.F. Metabolic syndrome complicated by peripheral arterial disease: clinical study of 5 cases. Natl Med J China (Chin. 2006;86(30):2114–2116. [PubMed] [Google Scholar]
  • 32.Hu D.Y., Pan C.Y., Yu J.M. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J. 2006;27(21):2573–2579. doi: 10.1093/eurheartj/ehl207. [DOI] [PubMed] [Google Scholar]

Articles from Chinese Journal of Integrative Medicine are provided here courtesy of Nature Publishing Group

RESOURCES